Details for Patent: 8,715,623
Summary for Patent: 8,715,623
| Title: | Pulmonary delivery of aminoglycoside |
| Abstract: | A dispersible powder composition comprises aminoglycoside for delivery to the lungs. The composition is effective to provide a therapeutically effective therapy via administration of less than 6 respirable unit doses by inhalation, wherein each unit dose comprises a volume of 0.30 to 0.95 mL. |
| Inventor(s): | Thomas E. Tarara, Jeffry G. Weers, Geraldine Venthoye |
| Assignee: | Novartis AG , BGP Products Operations GmbH |
| Application Number: | US11/981,986 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Device; Dosage form; |
Drugs Protected by US Patent 8,715,623
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,715,623
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 508735 | ⤷ Start Trial | |||
| Australia | 2002361897 | ⤷ Start Trial | |||
| Canada | 2468958 | ⤷ Start Trial | |||
| Cyprus | 1112560 | ⤷ Start Trial | |||
| Denmark | 1458360 | ⤷ Start Trial | |||
| European Patent Office | 1458360 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
